NLRP3 and serum lipopolysaccharide activity: To confirm the therapeutic effect of 8A on NLRP3 inflammasome-related diseases, we used an LPS-induced murine endotoxemia model and found that 8A significantly increased the survival of mice with sepsis (Fig. 5A).